47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.2 - Retail trade of food, beverages, and tobacco products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,8 | 1,5 | 1,4 | -5,3 |
EBITDA | 1,9 | 1,6 | 1,5 | -5,2 |
Short time liabilities | 1,4 | 1,7 | 2,1 | 28,3 |
Equity capital | 2,8 | 2,6 | 2,4 | -7,2 |
Operating profit (EBIT) | 1,8 | 1,5 | 1,4 | -5,3 |
Assets | 4,1 | 4,3 | 4,6 | 6,6 |
Net profit (loss) | 1,8 | 1,5 | 1,4 | -5,3 |
Cash | 0 | 0 | 0 | -0,3 |
Net income from sale | 16,7 | 19,5 | 21,1 | 8,3 |
Liabilities and provisions for liabilities | 1,4 | 1,7 | 2,1 | 28,2 |
Working assets | 2,5 | 2,6 | 3 | 15,7 |
Depreciation | 0,1 | 0,1 | 0,1 | -4,6 |
% | % | % | p.p. | |
Profitability of capital | 66,1 | 57,1 | 58,3 | 1,2 |
Equity capital to total assets | 66,7 | 61 | 53,1 | -7,9 |
Gross profit margin | 10,9 | 7,7 | 6,7 | -1 |
EBITDA Margin | 11,3 | 8,1 | 7,1 | -1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 31 | 37 | 6 |
Current financial liquidity indicator | 1.8196362257003784 | 1.552625298500061 | 1.4013093709945679 | -0,2 |
Net dept to EBITDA | 0.08415422588586807 | 0.030015531927347183 | -0.013737227767705917 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane